Next 10 |
TAAT Global Alternatives Inc. (TOBAF) is expected to report for quarter end 2024-01-31 ABCO Energy (ABCE) is expected to report for quarter end 2023-12-31 GameSquare Holdings Inc. (GAME) is expected to report $-0.26 for Q1 2023 Skillsoft Corp. Class A (SKIL) is expected to report $-3....
QUADIENT S.A ADR (NPACY) is expected to report for quarter end 2024-01-31 Jeffs' Brands Ltd (JFBR) is expected to report for quarter end 2023-12-31 Avid Bioservices Inc. (CDMO) is expected to report $0.02 for Q3 2024 TAAT Global Alternatives Inc. (TOBAF) is expected to report for quar...
Webcast to Provide Company Update on March 5, 2024 VANCOUVER, Washington, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications...
VANCOUVER, Washington, Feb. 01, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the Company has submitted its revise...
2024-01-29 08:50:04 ET More on CytoDyn Financial information for CytoDyn Read the full article on Seeking Alpha For further details see: CytoDyn appoints Jacob Lalezari as CEO, Mitchell Cohen as interim CFO
VANCOUVER, Washington, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Jacob Lalezari, formerly interim...
Cytodyn Inc (CYDY) is expected to report for Q2 2024 SeaChange International Inc. (SEAC) is expected to report for quarter end 2023-10-31 United Microelectronics Corporation (NEW) (UMC) is expected to report $0.15 for Q4 2023 Safestore Hldgs Plc (SFSHF) is expected to report for Q4 20...
SeaChange International Inc. (SEAC) is expected to report for quarter end 2023-10-31 Helen of Troy Limited (HELE) is expected to report $2.46 for Q3 2024 Commercial Metals Company (CMC) is expected to report $1.43 for Q1 2024 Pure Cycle Corporation (PCYO) is expected to report for Q1 ...
VANCOUVER, Washington, Dec. 07, 2023 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Jacob P. Lalezari, interim Chief...
2023-11-21 09:22:34 ET More on CytoDyn Financial information for CytoDyn For further details see: CytoDyn appoints Lalezari as its interim CEO
News, Short Squeeze, Breakout and More Instantly...
TAAT Global Alternatives Inc. (TOBAF) is expected to report for quarter end 2024-01-31 ABCO Energy (ABCE) is expected to report for quarter end 2023-12-31 GameSquare Holdings Inc. (GAME) is expected to report $-0.26 for Q1 2023 Skillsoft Corp. Class A (SKIL) is expected to report $-3....
QUADIENT S.A ADR (NPACY) is expected to report for quarter end 2024-01-31 Jeffs' Brands Ltd (JFBR) is expected to report for quarter end 2023-12-31 Avid Bioservices Inc. (CDMO) is expected to report $0.02 for Q3 2024 TAAT Global Alternatives Inc. (TOBAF) is expected to report for quar...
Webcast to Provide Company Update on March 5, 2024 VANCOUVER, Washington, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications...